Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Intellipharmaceutics International Inc (NASDAQ:IPCI)

0.891
Delayed Data
As of 4:00pm ET
 -0.0422 / -4.52%
Today’s Change
0.81
Today|||52-Week Range
3.35
-68.63%
Year-to-Date
No recent news for Intellipharmaceutics International Inc.

Today’s Trading

Previous close0.93
Today’s open0.88
Day’s range0.88 - 0.94
Volume220,388
Average volume (3 months)314,391
Market cap$28.9M
Dividend yield--
Data as of 4:00pm ET, 08/22/2017

Growth & Valuation

Earnings growth (last year)-22.58%
Earnings growth (this year)+68.42%
Earnings growth (next 5 years)+8.00%
Revenue growth (last year)-45.11%
P/E ratio--
Price/Sales32.70
Price/Book24.91

Competitors

 Today’s
change
Today’s
% change
PTXPernix Therapeutics ...+0.07+2.69%
VKTXViking Therapeutics ...+0.02+1.96%
TPIVTapImmune Inc+0.07+2.38%
CBLICleveland Biolabs In...+0.08+3.00%
Data as of 4:00pm ET, 08/22/2017

Financials

Next reporting dateOctober 3, 2017
EPS forecast (this quarter)-$0.02
Annual revenue (last year)$2.2M
Annual profit (last year)-$10.1M
Net profit margin-451.43%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, CEO &
Co-Chief Scientific Officer
Isa Odidi
President, Chief Operating Officer &
Director
Amina Odidi
Corporate headquarters
Toronto, Ontario

Forecasts